CNP advised Fund Singapore on the funding of equity investment for ClearBridge BioMedics Pte. Ltd.

Deals and cases

CNP advised Fund Singapore on the funding of equity investment for ClearBridge BioMedics Pte. Ltd.

Thursday 26 July 2018

Colin Ng & Partners LLP (“CNP”) advised Fund Singapore Pte. Ltd.—a financial institution regulated by the Monetary Authority of Singapore (MAS), and Singapore’s premier equity and lending-based crowdfunding company – on the funding of $1,165,000 equity investment for ClearBridge BioMedics, a Singapore Bio-Medical company. The company is targeting an Initial Public Offering (IPO) in the fourth quarter of 2018 and this is part of their $6.6million Pre-IPO fundraising effort.

Mr Christopher Huang (Partner), Mr Randall Perera (Senior Associate) and Mr Rajkumar Mannar (Associate) advised Fund Singapore Pte. Ltd. in this transaction.